COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Providers Increasingly Adopt Value-Based Care, Leveraging Top-Performing Consulting Expertise: Black Book Research Client Survey
Black Book survey reveals healthcare providers turning to advisory firms for value-based care consulting to enhance care delivery, data analytics, and collaboration. Emphasis on outcome-driven reimbursement models for improved patient outcomes and cost savings -
-
COMMUNIQUÉ DE PRESSE
Houston-Based Home Goods Company, Ozarke, Expands into Canadian Market with Launch of ozarke.ca
Ozarke expands into the Canadian market with the launch of ozarke.ca, offering a wide selection of sustainable home decor products. CEO Alex Elsaadi shares plans for future international market expansion -
COMMUNIQUÉ DE PRESSE
ASTCT Supports the FDA’s Accelerated Approval of AMTAGVI for Treatment of Metastatic Melanoma
The American Society for Transplantation and Cellular Therapy supports FDA's accelerated approval of lifileucel for unresectable or metastatic melanoma, offering new hope in solid tumor cancer treatment -
COMMUNIQUÉ DE PRESSE
STEICO: Preliminary business figures for 2023: Sales decline by 17.9% to € 365.3 million (e), EBIT ratio at 8.4% (e). Stable development expected for 2024
STEICO SE's preliminary business figures for 2023 show a 17.9% sales decline to €365.3 million. EBIT ratio is at 8.4%. Stable development expected for 2024 amid improving demand for ecological construction products -
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: LR GLOBAL HOLDING GMBH GIVES NOTICE OF CONDITIONAL VOLUNTARY TOTAL REDEMPTION OF ITS OUTSTANDING 2021/2025 BONDS AND LR HEALTH & BEAUTY SE ISSUES NEW SENIOR SECURED BONDS OF EUR 130 MILLION
LR Global Holding GmbH announces conditional voluntary total redemption of its outstanding 2021/2025 bonds and issuance of new senior secured bonds by LR Health & Beauty SE totaling EUR 130 million -
-
COMMUNIQUÉ DE PRESSE
Exasol announces preliminary figures for the 2023 financial year and outlook for 2024
Exasol announces preliminary figures for the 2023 financial year with an 18.1% increase in ARR to EUR 41.7 million and an improved adjusted EBITDA of EUR -5.4 million. Outlook for 2024 includes up to 10% ARR growth and stable cash reserves above EUR 10 million
